RecruitingPhase 3NCT07686263
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Oklahoma City, OK · +33 more sites
Schizophrenia clinical trials in Oklahoma City, OK
5 recruiting schizophrenia studies with a site in Oklahoma City, OK.
RecruitingPhase 3NCT06229210
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Sponsor: Intra-Cellular Therapies, Inc.
Oklahoma City, OK · +57 more sites
RecruitingPhase 3NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Oklahoma City, OK · +101 more sites
RecruitingPhase not listedNCT07379827
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Sponsor: Bristol-Myers Squibb
Oklahoma City, OK · Tulsa, OK · +53 more sites
RecruitingPhase 3NCT05184335
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Sponsor: Reviva Pharmaceuticals
Oklahoma City, OK · +17 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.